Bank of America Discloses Over 5% Stake in Galapagos NV
GLPG sits 50% above its 52-week low of $22.591.
Summary
Bank of America Corporation has reported crossing the 5% ownership threshold in Galapagos NV, acquiring a significant stake through direct voting rights and equivalent financial instruments.
Key Events · Ownership and Investor Activity · GLPG
-
Bank of America Crosses 5% Ownership
Bank of America Corporation disclosed that it crossed the 5% ownership threshold in Galapagos NV on February 9, 2026, now holding 5.34% of voting rights.
-
Substantial Institutional Investment
The reported stake, comprising direct voting rights and equivalent financial instruments, represents an approximate $119 million investment by the financial institution.
-
Follows Strategic Shift
This significant institutional stake comes after Galapagos' January 5, 2026 announcement to wind down its cell therapy activities, potentially signaling confidence in the company's refocused strategy.
Analysis · GLPG · Life Sciences
This filing reveals that Bank of America Corporation, a major institutional investor, has accumulated a substantial stake in Galapagos NV, now holding 5.34% of the company's voting rights and equivalent financial instruments. This acquisition, valued at approximately $119 million, represents a significant institutional investment and could be interpreted as a vote of confidence in Galapagos' strategic direction, particularly following the company's recent decision to wind down its cell therapy activities. Such a large stake by a prominent financial entity may attract further investor attention.
How filings like this one have moved
In the 30 days to Sep 19, 2026, 29.7% of the 1695 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GLPG was trading at $33.92 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $22.59 to $37.78. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.